Ramipril Shortage Alert: What UK Patients Taking Blood Pressure Medication Need to Know
Thousands of people across the UK rely on Ramipril every day to help manage high blood pressure and protect their heart health. However, patients taking certain versions of this commonly prescribed medication have been warned about supply problems affecting pharmacies.
A shortage alert has been issued for Ramipril 1.25mg capsules, with healthcare organisations advising patients not to panic but to speak with their pharmacist before their next prescription is due. The situation does not mean that all Ramipril medicines have disappeared from supplies, but some specific formulations are currently affected.
For people who take Ramipril regularly, understanding what is happening and knowing what steps to take can help prevent unnecessary worry.
Why Has a Shortage Alert Been Issued?
According to reports monitoring UK medicine supplies, a serious shortage protocol has been activated for Ramipril 1.25mg capsules. This means pharmacies have specific guidance on how to manage limited supplies and provide medication safely to patients.
The shortage affects Ramipril 1.25mg capsules across England, Scotland, Wales and Northern Ireland. Under the Serious Shortage Protocol, pharmacies may provide a reduced quantity of medication compared with what a patient normally receives. For example, someone who usually receives a longer supply may temporarily receive up to one month of medication depending on availability and official guidance.
The purpose of these measures is to help ensure that available stock can be distributed fairly while alternative arrangements are considered.
What Is Ramipril Used For?
Ramipril belongs to a group of medicines called ACE inhibitors. These medicines are commonly prescribed to treat high blood pressure, also known as hypertension.
Lowering high blood pressure is important because uncontrolled hypertension can increase the risk of serious health problems, including heart disease, stroke and kidney complications.
Doctors may also prescribe Ramipril for certain heart conditions or to help protect kidney function in some patients. Because it is widely used, any disruption to its supply can affect a large number of people.
Ramipril is popular among healthcare professionals because it is usually taken once daily and remains active in the body for an extended period.
Does the Shortage Affect All Ramipril Medicines?
No. The shortage warning relates specifically to Ramipril 1.25mg capsules.
Other forms, including some Ramipril tablets and oral solutions, remain available. However, health authorities have warned that switching large numbers of patients to alternative forms could put additional pressure on supplies.
This is why patients should not automatically request a different strength or formulation without speaking to a healthcare professional. A change in medication type or dosage should always be managed carefully.
What Should Patients Taking Ramipril Do?
People currently taking Ramipril should continue following their prescription instructions unless advised otherwise by a doctor or pharmacist.
Patients are encouraged to:
- Check their medication supply before they run out
- Contact their pharmacy if they are concerned about future availability
- Ask their pharmacist about possible alternatives if their usual capsules are unavailable
- Avoid changing their dose without medical advice
- Continue taking prescribed medication as directed
Stopping blood pressure medication suddenly without professional guidance may cause health risks, especially for people who rely on it to control an ongoing condition.
Ramipril Recall Issue Explained
Alongside the supply shortage, there has also been a separate safety issue involving a batch of Ramipril 10mg capsules.
A Class 2 recall was reportedly issued for one batch manufactured by Crescent Pharma because some packaging contained incorrect blister strips. Some boxes labelled as containing 10mg capsules reportedly contained 5mg strips instead.
This recall is different from the shortage. The recall relates to a packaging mistake, while the shortage relates to availability problems.
Patients who have concerns about their medication packaging should contact their pharmacy for advice.
Another Blood Pressure Medicine Also Affected
Ramipril is not the only cardiovascular medicine being monitored for supply issues.
Propranolol modified-release capsules have also been listed under a shortage alert. Propranolol is another commonly used medicine and may be prescribed for conditions including high blood pressure, migraine prevention, anxiety symptoms and essential tremor.
The shortage concerns the slow-release capsule versions. Immediate-release Propranolol tablets remain available according to current information.
If a patient needs to switch between different versions of Propranolol, their doctor may need to adjust the timing and dosage because slow-release and immediate-release medicines work differently.
Why Medicine Shortages Happen
Medication shortages can occur for several reasons, including manufacturing problems, increased demand, supply chain disruption, regulatory issues or difficulties obtaining raw materials.
Modern medicine supply networks involve multiple stages, from manufacturing and packaging to transportation and pharmacy distribution. A problem at any stage can affect availability.
Healthcare organisations usually respond by monitoring stock levels, issuing guidance to pharmacies and identifying suitable alternatives where possible.
The Importance of Speaking With Your Pharmacist
Community pharmacists play an important role during medicine shortages. They can check available supplies, explain official guidance and advise patients on the safest options.
Patients should avoid relying on online rumours or changing medicines without professional advice. Pharmacy teams have access to the latest information and can provide practical support.
If someone is running low on Ramipril, contacting their pharmacy early is usually the best approach.
Conclusion
The current Ramipril shortage alert mainly affects specific 1.25mg capsule supplies rather than all versions of the medicine. While the situation may cause concern for patients who depend on this treatment, guidance is available to help manage supply issues safely.
Patients should continue taking their medication as prescribed and speak with their pharmacist if they experience problems obtaining their usual supply.
Medicine shortages can be stressful, but healthcare professionals are working to ensure patients receive appropriate treatment and support during periods of limited availability.
Sources
- The Mirror report, published 5 August 2026.
- Department of Health and Social Care (DHSC) Serious Shortage Protocol information relating to Ramipril 1.25mg capsules.
- NHS guidance on blood pressure medicines and ACE inhibitors.
- Medicines and Healthcare products Regulatory Agency (MHRA) information on medicine recalls.
Disclaimer
This article is for general information purposes only and is not medical advice. Do not stop, change or replace any prescribed medication without speaking to a qualified healthcare professional. If you have concerns about Ramipril or any other medicine, contact your doctor or pharmacist for personalised guidance.